Browsing by Author Jourdain G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 33  next >
Issue DateTitleAuthor(s)
2013Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspringKhamduang W.; Gaudy-Graffin C.; Ngo-Giang-Huong N.; Jourdain G.; Moreau A.; Borkird T.; Layangool P.; Kamonpakorn N.; Jitphiankha W.; Kwanchaipanich R.; Potchalongsin S.; Lallemant M.; Sirirungsi W.; Goudeau A.
2010Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failureJourdain G.; Wagner T.A.; Ngo-Giang-Huong N.; Sirirungsi W.; Klinbuayaem V.; Fregonese F.; Nantasen I.; Techapornroong M.; Halue G.; Nilmanat A.; Wittayapraparat P.; Chalermpolprapa V.; Pathipvanich P.; Yuthavisuthi P.; Frenkel L.M.; Lallemant M.
2008Characteristics of HIV type 1 (HIV-1) glycoprotein 120 env sequences in mother-infant pairs infected with HIV-1 subtype CRF01_AESamleerat T.; Braibant M.; Jourdain G.; Moreau A.; Ngo-Giang-Huong N.; Leechanachai P.; Hemvuttiphan J.; Hinjiranandana T.; Changchit T.; Warachit B.; Suraseranivong V.; Lallemant M.; Barin F.
2014Cost-effectiveness of early infant HIV diagnosis of HIV-exposed infants and immediate antiretroviral therapy in HIV-infected children under 24 months in ThailandCollins I.J.; Cairns J.; Ngo-Giang-Huong N.; Sirirungsi W.; Leechanachai P.; Coeur S.L.; Samleerat T.; Kamonpakorn N.; Mekmullica J.; Jourdain G.; Lallemant M.
2010Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: Comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assayWagner T.A.; Kress C.M.; Beck I.; Techapornroong M.; Wittayapraparat P.; Tansuphasawasdikul S.; Jourdain G.; Ngo-Giang-Huong N.; Lallemant M.; Frenkel L.M.
2008Early HIV-I diagnosis using in-house real-time PCR amplification on dried blood spots for infants in remote and resource-limited settingsNgo-Giang-Huong N.; Khamduang W.; Leurent B.; Collins I.; Nantasen I.; Leechanachai P.; Sirirungsi W.; Limtrakul A.; Leusaree T.; Comeau A.M.; Lallemant M.; Jourdain G.
2009Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai womenCressey T.R.; Van Dyke R.; Jourdain G.; Puthanakit T.; Roongpisuthipong A.; Achalapong J.; Yuthavisuthi P.; Prommas S.; Chotivanich N.; Maupin R.; Smith E.; Shapiro D.E.; Mirochnick M.
2010Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapineLallemant M.; Ngo-Giang-Huong N.; Jourdain G.; Traisaithit P.; Cressey T.R.; Collins I.J.; Jarupanich T.; Sukhumanant T.; Achalapong J.; Sabsanong P.; Chotivanich N.; Winiyakul N.; Ariyadej S.; Kanjanasing A.; Ratanakosol J.; Hemvuttiphan J.; Kengsakul K.; Wannapira W.; Sittipiyasakul V.; Pornkitprasarn W.; Liampongsabuddhi P.; Mcintosh K.; Van Dyke R.B.; Frenkel L.M.; Koetsawang S.; Le Coeur S.; Kanchana S.
2012Envelope glycoproteins of Human Immunodeficiency Virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological propertiesThenin S.; Samleerat T.; Tavernier E.; Ngo-Giang-Huong N.; Jourdain G.; Lallemant M.; Barin F.; Braibant M.
2014Estimating the timing of mother-to-child transmission of the human immunodeficiency virus type 1 using a viral molecular evolution modelChaillon A.; Samleerat T.; Zoveda F.; Ballesteros S.; Moreau A.; Ngo-Giang-Huong N.; Jourdain G.; Gianella S.; Lallemant M.; Depaulis F.; Barin F.
2013Five-year trends in antiretroviral usage and drug costs in HIV-infected children in ThailandCollins I.; Cairns J.; Le Coeur S.; Pagdi K.; Ngampiyaskul C.; Layangool P.; Borkird T.; Na-Rajsima S.; Wanchaitanawong V.; Jourdain G.; Lallemant M.
2010Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in ThailandBriand N.; Le Coeur S.; Jourdain G.; Hotrawarikarn S.; Sirinontakan S.; Hinjiranandana T.; Kanjanavanit S.; Traisathit P.; McIntosh K.; Lallemant M.
2010Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in ThailandBriand N.; Le Coeur S.; Jourdain G.; Hotrawarikarn S.; Sirinontakan S.; Hinjiranandana T.; Kanjanavanit S.; Traisathit P.; McIntosh K.; Lallemant M.
2012High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited settingPuthanakit T.; Jourdain G.; Suntarattiwong P.; Chokephaibulkit K.; Siangphoe U.; Suwanlerk T.; Prasitsuebsai W.; Sirisanthana V.; Kosalaraksa P.; Petdachai W.; Hansudewechakul R.; Waranawat N.; Ananworanich J.; Bunupuradah T.; Phasomsap C.; Kaew-on P.; Kanjanavanit S.; Hinjiranandana T.; Layangool P.; Kamonpakorn N.; Buranabanjasatean S.; Ngampiyaskul C.; Chotpitayasunondh T.; Chanpradub S.; Leawsrisuk P.; Chearskul S.; Vanprapar N.; Phongsamart W.; Lapphra K.; Chearskul P.; Wittawatmongkol O.; Intalapaporn K.; Kongstan N.; Pannin N.; Maleesatharn A.; Khumcha B.; Aurpibul L.; Wongnum N.; Nadsasarn R.; Lumbiganon P.; Tharnprisan P.; Udompanich T.; Yentang M.; Khonponoi A.; Maneerat N.; Denjunta S.; WatanapornS.; Yodsuwan C.; Srisuk W.; Somsri S.; Surapanichadul K.
2010HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapyPuthanakit T.; Jourdain G.; Hongsiriwon S.; Suntarattiwong P.; Chokephaibulkit K.; Sirisanthana V.; Kosalaraksa P.; Petdachai W.; Hansudewechakul R.; Siangphoe U.; Suwanlerk T.; Ananworanich J.
2010HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapyPuthanakit T.; Jourdain G.; Hongsiriwon S.; Suntarattiwong P.; Chokephaibulkit K.; Sirisanthana V.; Kosalaraksa P.; Petdachai W.; Hansudewechakul R.; Siangphoe U.; Suwanlerk T.; Ananworanich J.
2012Hospitalization trends, costs, and risk factors in HIV-infected children on antiretroviral therapyCollins I.J.; Cairns J.; Jourdain G.; Fregonese F.; Nantarukchaikul M.; Lertpienthum N.; Wannarit P.; Attavinijtrakarn P.; Layangool P.; Le Coeur S.; Lallemant M.
2010Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in ThailandNgo-Giang-Huong N.; Jourdain G.; Sirirungsi W.; Decker L.; Khamduang W.; Le Coeur S.; Sirinontakan S.; Somsamai R.; Pagdi K.; Hemvuttiphan J.; McIntosh K.; Barin F.; Lallemant M.
2011Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected thai patients receiving indinavir boosted with ritonavirCressey T.R.; Urien S.; Hirt D.; Halue G.; Techapornroong M.; Bowonwatanuwong C.; Leenasirimakul P.; Treluyer J.-M.; Jourdain G.; Lallemant M.
2004Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infantsPrasitwattanaseree S.; Lallemant M.; Costagliola D.; Jourdain G.; Mary J.-Y.